North Star Investment Management Corp. Biogen Inc. Transaction History

North Star Investment Management Corp.

$1.43 Billion
Q3 2024

A detailed history of North Star Investment Management Corp. transactions in Biogen Inc. stock. As of the latest transaction made, North Star Investment Management Corp. holds 5,622 shares of BIIB stock, worth $823,454. This represents 0.08% of its overall portfolio holdings.

Number of Shares

5,622

Previous 5,634 0.21%

Holding current value

$823,454

Previous $1.31 Million 16.62%

% of portfolio

0.08%

Previous 0.1%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	SELL	$189.07 - $236.8 $2,268 - $2,841	-12 Reduced 0.21%	5,622 $1.09 Million
Q4 2023 Jan 10, 2024	SELL	$222.59 - $267.94 $1,112 - $1,339	-5 Reduced 0.09%	5,634 $1.46 Million
Q3 2023 Nov 06, 2023	SELL	$253.3 - $285.89 $5,066 - $5,717	-20 Reduced 0.35%	5,639 $1.45 Million
Q1 2023 Apr 27, 2023	BUY	$256.56 - $292.34 $1.42 Million - $1.62 Million	5,551 Added 5139.81%	5,659 $1.57 Million
Q4 2022 Jan 11, 2023	SELL	$252.44 - $306.72 $13,379 - $16,256	-53 Reduced 32.92%	108 $0
Q3 2022 Nov 02, 2022	SELL	$194.69 - $268.46 $6,230 - $8,590	-32 Reduced 16.58%	161 $43,000
Q1 2022 May 03, 2022	SELL	$193.77 - $244.14 $37,203 - $46,874	-192 Reduced 49.87%	193 $41,000
Q4 2021 Feb 07, 2022	BUY	$223.92 - $287.77 $44,336 - $56,978	198 Added 105.88%	385 $92,000
Q3 2021 Oct 20, 2021	SELL	$282.99 - $369.05 $2,546 - $3,321	-9 Reduced 4.59%	187 $53,000
Q2 2021 Jul 13, 2021	BUY	$259.0 - $414.71 $6,216 - $9,953	24 Added 13.95%	196 $68,000
Q1 2021 Apr 19, 2021	SELL	$242.95 - $284.63 $101,067 - $118,406	-416 Reduced 70.75%	172 $48,000
Q4 2020 Jan 12, 2021	BUY	$236.26 - $355.63 $15,120 - $22,760	64 Added 12.21%	588 $144,000
Q3 2020 Oct 13, 2020	BUY	$264.77 - $305.71 $137,680 - $158,969	520 Added 13000.0%	524 $149,000
Q1 2020 Apr 23, 2020	BUY	$268.85 - $341.04 $1,075 - $1,364	4 New	4 $1,000
Q3 2019 Oct 03, 2019	SELL	$217.44 - $243.88 $500,112 - $560,924	-2,300 Closed	0 $0
Q2 2019 Jul 15, 2019	BUY	$219.29 - $241.72 $113,372 - $124,969	517 Added 29.0%	2,300 $538,000
Q1 2019 Apr 10, 2019	BUY	$216.71 - $338.96 $386,393 - $604,365	1,783 New	1,783 $421,000
Q3 2018 Oct 11, 2018	SELL	$293.51 - $383.83 $10,859 - $14,201	-37 Closed	0 $0
Q1 2018 Apr 13, 2018	SELL	$260.13 - $367.91 $1,560 - $2,207	-6 Reduced 13.95%	37 $10,000
Q3 2017 Oct 06, 2017	BUY	$281.15 - $329.69 $12,089 - $14,176	43	43 $13,000

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of North Star Investment Management Corp., based on Form 13F filings with the SEC.

News

Stay updated on North Star Investment Management Corp. with notifications on news.

Account

North Star Investment Management Corp. Biogen Inc. Transaction History